This project provides financing to Mabion S.A. to cover the cost of the expansion of production capacity in Konstantynow Lodzki, Poland, and costs and expenses related to the development and commercialization of Mabion CD20.
Mabion is a leading biotechnology company in Poland, listed on the Warsaw Stock Exchange (WSE), created for the purpose of marketing cutting-edge biotechnological drugs based on humanised monoclonal antibodies.
+48 42 207 78 90
+48 42 203 27 03
gen. Mariana Langiewicza 60 street 95-050 Konstantynów Lódzki
ACCOUNTABILITY MECHANISM OF EBRD
The Project Complaint Mechanism (PCM) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an European Bank for Reconstruction and Development (EBRD)-financed project. If you submit a complaint to the PCM, it may assess compliance with EBRD's own policies and procedures to prevent harm to the environment or communities or it may assist you in resolving the problem that led to the complaint through a dialogue with those implementing the project. Additionally, the PCM has the authority to recommend a project be suspended in the event that harm is imminent. You can contact the PCM at firstname.lastname@example.org or you can submit a complaint online using an online form, http://www.ebrd.com/eform/pcm/complaint_form?language=en. You can learn more about the PCM and how to file a complaint at http://www.ebrd.com/work-with-us/project-finance/project-complaint-mechanism.html.